Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered breathing comprising mild-to-moderate obstructive sleep apnea. Vivos Therapeutics Inc. is based in Highlands Ranch, Colorado.
| Revenue (Most Recent Fiscal Year) | $15.03M |
| Net Income (Most Recent Fiscal Year) | $-11.14M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 2.40 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 5.90 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -99.49% |
| Net Margin (Trailing 12 Months) | -99.49% |
| Return on Equity (Trailing 12 Months) | -232.76% |
| Return on Assets (Trailing 12 Months) | -84.30% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.05 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.05 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 1.69 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.61 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.55 |
| Earnings per Share (Most Recent Fiscal Year) | $-2.22 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.68 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 7.50M |
| Free Float | 7.28M |
| Market Capitalization | $34.49M |
| Average Volume (Last 20 Days) | 0.19M |
| Beta (Past 60 Months) | 7.03 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 3.00% |
| Percentage Held By Institutions (Latest 13F Reports) | 26.35% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |